Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study — Roberto Diletti (2014) | RDL Network
Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study
European Heart Journal 35(12): 777-786
Article 2014 English
Authors
RD
Roberto Diletti
ΑΚ
Αντώνιος Καρανάσος
TM
Takashi Muramatsu
Abstract
1 min read
AimsWe evaluated the feasibility and the acute performance of the everolimus-eluting bioresorbable vascular scaffolds (BVS) for the treatment of patients presenting with ST-segment elevation myocardial infarction (STEMI).
Salvatore Brugaletta, Tommaso Gori, Adrian F. Low, Petr Toušek, Eduardo Pinar, Josep Gómez‐Lara, Giancarla Scalone, Eberhard Schulz, Mark Y. Chan, Viktor Kočka, José Hurtado, Juan Antoni Gomez-Hospital, Thomas Münzel, Chi‐Hang Lee, Ángel Cequier, Mariano Valdés, Petr Widimský, Patrick W. Serruys, Manel Sabaté
Roberto Diletti, Nicolas M. Van Mieghem, Takashi Muramatsu, Carl Schultz, Evelyn Regar, Peter de Jaegere, Felix Zijlstra, Αντώνιος Καρανάσος, Patrick W. Serruys, Robert‐Jan van Geuns
Roberto Diletti, Yuki Ishibashi, Cordula Felix, Yoshinobu Onuma, Shimpei Nakatani, Nicolas M. Van Mieghem, Eveliyn Regar, Marco Valgimigli, Peter P. de Jaegere, Nienke van Ditzhuijzen, Jiang Ming Fam, Jürgen Ligthart, Mattie Lenzen, Patrick W. Serruys, Felix Zijlstra, Robert‐Jan van Geuns
Discussion(0)
No comments yet. Be the first to comment.